International Biotechnology Trust’s bluebird bio BLUE Stock Holding History

International Biotechnology Trust’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-849	Closed	-$210K	–	76
2021 Q3	$210K	Hold	849	–	–	0.05%	66
2021 Q2	$351K	Hold	849	–	–	0.09%	63
2021 Q1	$332K	Hold	849	–	–	0.09%	54
2020 Q4	$476K	Hold	849	–	–	0.13%	49
2020 Q3	$593K	Hold	849	–	–	0.19%	49
2020 Q2	$660K	Hold	849	–	–	0.22%	48
2020 Q1	$505K	Sell	849 -463	-35%	-$451K	0.23%	51
2019 Q4	$1.49M	Hold	1,312	–	–	0.54%	40
2019 Q3	$1.56M	Hold	1,312	–	–	0.72%	30
2019 Q2	$2.16M	Hold	1,312	–	–	0.8%	32
2019 Q1	$2.67M	Hold	1,312	–	–	0.99%	34
2018 Q4	$1.32M	Hold	1,312	–	–	0.82%	29
2018 Q3	$1.9M	Sell	1,312 -232	-15%	-$479K	0.9%	32
2018 Q2	$3.14M	Hold	1,544	–	–	1.2%	27
2018 Q1	$3.41M	Hold	1,544	–	–	1.33%	22
2017 Q4	$3.56M	Hold	1,544	–	–	1.26%	25
2017 Q3	$2.75M	Buy	+1,544	New	+$2.16M	1.07%	31

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

International Biotechnology Trust's BLUE Position: Q4 2021 in Review

International Biotechnology Trust sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 849 shares — an estimated $210K sold.

International Biotechnology Trust first reported a position in BLUE in Q3 2017 and held it in 17 quarters. The position peaked at $3.56M in Q4 2017. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

International Biotechnology Trust reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
International Biotechnology Trust sold 849 bluebird bio shares in Q4 2021, an estimated $210K.
International Biotechnology Trust first reported a position in bluebird bio in Q3 2017 and held it in 17 quarters.
International Biotechnology Trust's bluebird bio position peaked at $3.56M in Q4 2017.
172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on International Biotechnology Trust's 13F filing for Q4 2021, filed 15 Feb 2022.